The peptide encyclopedia

NNMT inhibitor small molecule studied for metabolism.

hGH fragment studied for fat metabolism.

Amylin analog studied alongside semaglutide (CagriSema).

Once-weekly GLP-1 and glucagon receptor dual agonist approved in China (2025) for weight management and type 2 diabetes; not FDA-approved.

Lilly's oral small-molecule GLP-1 — the first daily GLP-1 pill without food restrictions.

Triple-agonist (GLP-1/GIP/glucagon) drawing the most research interest of any current weight compound.

The original blockbuster GLP-1 (Ozempic/Wegovy).

Dual glucagon/GLP-1 receptor agonist studied in clinical obesity and metabolic-disease trials.

Dual GIP/GLP-1 receptor agonist behind Mounjaro and Zepbound.

Erythropoietin-derived peptide studied for neuropathic pain and inflammation research.

The most-discussed recovery peptide in the research community.

Tripeptide fragment of alpha-MSH studied in inflammation and gut-barrier research models.

The human antimicrobial peptide, studied in biofilm and immune-defense research.

Arginate salt presentation of the BPC-157 sequence with no distinct human or animal evidence located.

Recovery peptide frequently stacked with BPC-157.

Immune-modulation research peptide.

Neuropeptide studied in immune, inflammation, vascular, and gastrointestinal signaling research.

Telomerase-studied peptide in longevity research.

Experimental senolytic peptide reported in cultured cells and mice, with no human trial or validated dose.

Copper tripeptide studied for skin and tissue applications.

The body's master antioxidant, compared here across single-vial lab formats.

Synthetic native GnRH; the human diagnostic product Factrel is discontinued, and US gonadorelin today is veterinary or compounded.

FDA-approved gonadotropin used in selected fertility and endocrine indications under clinical monitoring.

Mitochondrial-derived peptide studied in cellular-stress, neuroprotection, and longevity research.

Master upstream regulator of the reproductive hormone axis.

Mitochondrial-derived peptide studied for metabolism.

Coenzyme studied for cellular energy and longevity research.

Nonapeptide hormone studied in bonding, social behavior, and neuroendocrine signaling research.

Melanocortin peptide studied for libido research.

Mitochondria-targeting tetrapeptide studied for cardiolipin and cellular-energy research.

Thymic extract peptide from the Khavinson course-based tradition.

GHRH analog commonly blended with ipamorelin.

Follistatin isoform whose only human evidence is a small muscular-dystrophy gene-transfer trial, not an injectable protein protocol.

Classic GH secretagogue; stronger pulse than GHRP-6 with less appetite effect.

Classic ghrelin-receptor secretagogue known for strong appetite stimulation.

The strongest short-block GH secretagogue; desensitizes fastest, run in short cycles.

Long R3 IGF-1 analog; matched only to explicit LR3 products, not DES or media-grade IGF variants.

Selective growth-hormone secretagogue, often paired with CJC-1295.

Pegylated IGF-1 splice variant studied in muscle-repair and tissue-growth research.

The original GHRH fragment; gentle growth-hormone support with a former-approved-product history.

GHRH analog researched for visceral fat.

Experimental Semax-family nootropic sold in two molecular-weight variants, with no published human or animal study located.

Prescription porcine brain-derived peptide mixture licensed in several countries as a 215.2 mg/mL solution; not FDA-approved. Lyophilized powders sold under the name are not the licensed product.

Angiotensin IV-derived compound studied in synaptogenesis and cognitive research models.

Sleep-architecture research peptide tracked as a single-vial product across lab vendors.

Experimental CNTF-derived peptide with oral animal studies only; no human trial located.

Khavinson tripeptide bioregulator studied in brain-aging and neuroprotection research.

Anxiolytic-studied peptide, often compared with Semax.

Nootropic peptide studied in cognition research.

Copper-binding tripeptide studied in isolated human hair follicles and dermal papilla cells; no human trial.

The gentler first-generation tanning peptide; approved-twin pedigree (Scenesse).

Melanocortin agonist studied for pigmentation.

Topical-only anti-wrinkle peptide for expression lines; never injected.

Three-component recovery blend combining BPC-157, TB-500/TB4, and KPV.

Recovery research blend combining BPC-157 with TB-500/TB4 across vendor naming variants.

Growth-hormone research blend pairing CJC-1295 without DAC with ipamorelin.

Composition-matched GHK-Cu and KPV blend, including Beauty Blend and GHKPV labels.

Composition-matched GHK-Cu, BPC-157, and TB-500/TB4 blend, regardless of vendor naming.

Composition-matched GLOW-style blend with KPV added; matched by ingredients, not label alone.

Nootropic research blend combining Semax and Selank in the same vial.

Growth-hormone research blend pairing tesamorelin with ipamorelin.

Reconstitution supply compared by price per milliliter instead of price per milligram.